Pediatric Diabetes 2014 - Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium

Oct 3, 2026

Upload by Blitz

Pediatric Diabetes 2014 supplement introduces the ISPAD Clinical Practice Consensus Guidelines 2014 compendium, updating chapters originally published in 2006–2008 and consolidated in 2009. It highlights global childhood diabetes burden, emphasizing that inadequate insulin access remains a leading cause of preventable child deaths. The editorial describes international initiatives—such as IDF “Life for a Child” and ISPAD training and science schools—aimed at improving insulin availability, education, and care pathways worldwide.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages256

Reading Time10 h 45 min

AccessFree to download

Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium

Purpose and update history

Global burden and need for insulin access

International initiatives and training programs

ISPAD guidelines evolution and structure

Pediatric Diabetes 2014: 15(Suppl. 20): 1–3 doi: 10.1111/pedi.12182 All rights reserved © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Pediatric Diabetes Editorial Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium This supplement of Pediatric Diabetes is an update of the guideline chapters that were originally individually published in the journal between 2006 and 2008, and asa single compendium edition in2009. The chapters have been modiﬁed and updated to reﬂect the signiﬁcant advances in scientiﬁc knowledge and clinical care that have occurred since then. These updated guidelines also are available on the International Society for Pediatric and Adolescent Diabetes (ISPAD) website: [www.ispad.org](www.ispad.org). In 2007, the total child population of the world (0–14yr) was estimated to be 1.8billion, of whom 0.02% had diabetes. This means that approximately 497000 children around the world have diabetes, with 79000 new cases diagnosed each year (1) . However, ﬁeld data suggest that some individual country estimates (especially in developing countries) are uncertain or inaccurate. These very large numbers of children need help to survive with insulin injectionsin order to live a full life without restrictions or disabling complications and without being stigmatized for their diabetes. Even today, almost a century after the discovery of insulin, the most common cause of death in a child with diabetes from a global perspective is a lack of access to insulin (2) . Many children die before their diabetes is diagnosed. It is therefore of utmost importance that all forces unite to make it come true that no child should die from diabetes. A promising initiative has been taken by the International Diabetes Federation (IDF) ‘Life for a Child’ programme ([www.lifeforachild.org](www.lifeforachild.org)) in collaboration with ISPAD and other organizations. Several major companies that produce insulin and other diabetes-related products have pledged their support, and the number of children and youth provided with insulin, test strips, and other support is around 13000 in 2014 and will continue to increase. Currently 46 countries are involved. ISPAD has also pledged support and assistance in the training of pediatricians and health care professionalsin childhood and adolescent diabetes through its membership network. CDiC (Changing Diabetes in Children) is another initiative providing insulin and diabetes care to India, Bangladesh, and a number of countries in Africa. Additional initiatives by ISPAD to improve diabetes care for children and adolescents worldwide include its ‘science schools’ for physiciansand for other health care professions, its postgraduate courses and its Diabetes in Practice (DIP) programme, which have been held in a number of countries around the world. ISPAD also provides tutoring in collaboration with the European Society for Pediatric Endocrinology (ESPE) at Pediatric Endocrine and Diabetes Training Center in Africa (PETCA) in Nairobi and at Pediatric Endocrine and Diabetes Training Center in West Africa (PETCWA) in Lagos for fellows from Africa in pediatric diabetology and endocrinology. In 1993, members of the ISPAD formulated the Declaration of Kos, proclaiming their commitment to‘promote optimal health, social welfare, and quality of life for all children with diabetes around the world by the year 2000’. Although all the aims and ideals of the Declaration of Kos were not reached by 2000, we feel that slowly, by small steps, the worldwide care of children with diabetes is improving. ISPAD published its ﬁrst set of guidelines in 1995 (3), its second in 2000 (4), and its third in 2009 (5) . Since then, the acceptance of intensive therapy, also for very young children, has increased around the world. Insulin pump usage has risen in all age groups in countries where this treatment modality can be afforded. Intensive therapy requires better and mo

FAQs

What does the 2014 compendium update compared with earlier publications?

It updates guideline chapters originally published between 2006 and 2008 and previously consolidated into a single compendium in 2009, reflecting advances in scientific knowledge and clinical care.

Why is access to insulin emphasized in this editorial?

Insufficient access to insulin is described as the most common cause of death in children with diabetes globally, and many children die before diagnosis.

What international efforts are mentioned to improve childhood diabetes care?

The editorial cites the IDF “Life for a Child” programme, ISPAD support for training pediatricians and health professionals, science schools, postgraduate courses, and regional tutoring initiatives in Africa.

Oct 3, 2026

Upload by Blitz